设为首页| 加入收藏
网站首页 本刊简介 编委会 投稿指南 过刊浏览 联系我们 下载专区
最新消息:
位置:首页 >> 期刊文章
铁死亡在肝细胞癌中的研究进展
作者:窦婷1  朱向高2 3 4 5  杨昊2 3 
单位:1.内蒙古医科大学 内蒙古 呼和浩特 010010 2.内蒙古医科大学附属肿瘤医院、北京大学肿瘤医院内蒙古医院 放射治疗中心 内蒙古 呼和浩特 010020 3.内蒙古医科大学 放射物理与放射生物重点实验室 内蒙古 呼和浩特 010020 4.北京大学肿瘤医院暨北京市肿瘤防治研究所 放疗科 北京 1001425 5.北京大学肿瘤医院暨北京市肿瘤防治研究所 恶性肿瘤发病机制及转化研究教育部重点实验室 北京 100142 
关键词:铁死亡 肝细胞癌 谷胱甘肽过氧化物酶4 肿瘤治疗 
分类号:
出版年,卷(期):页码:2023,15(4):6-10
摘要:
摘要:铁死亡是一种区别于细胞凋亡的程序性细胞死亡形式,主要发生机制是二价铁 的增加或体内抗氧化系统失衡,产生大量脂质过氧化物,最后引发细胞死亡。铁死亡 参与多种癌症的发生,在癌症的发病机制中发挥重要作用。肝细胞癌(hepatocellular carcinoma,HCC)是中国最常见的恶性肿瘤,近年来大量研究表明铁死亡在HCC中的 发生机制和治疗不敏感以及获得性耐药方面发挥至关重要的作用,得到众多研究人员 的广泛关注。本文总结了铁死亡在HCC中的主要调节通路、关键调节因子以及在HCC 治疗中的潜在应用,为HCC的精准治疗提供新思路。
Abstract: Ferroptosis is a form of programmed cell death which is different from apoptosis, the main mechanism is the increase of bivalent iron or the imbalance of antioxidant system in vivo, which produces a large number of lipid peroxides and finally leads to cell death. Ferroptosis is involved in the occurrence of a variety of cancers and is considered to play an important role in the pathogenesis of cancer. Hepatocellular carcinoma (HCC) is the most common malignant tumor in China. In recent years, a large number of studies showed that ferroptosis played an important role in the pathogenesis, treatment insensitivity and acquired drug resistance of HCC, which had been widely concerned by many researchers. This paper summarized the main regulatory pathways and key regulatory factors of ferroptosis in HCC, as well as its potential application in the treatment of HCC, so as to provide new ideas for the accurate treatment of HCC.
基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】【加入收藏
 

地址:北京市朝阳区京顺东街8号
邮政编码:100015  电话:010-84322058  传真:010-84322059 Email:editordt@163.com